SCHEMBL21691673

SCHEMBL21691673

N#Cc1ccc(-c2cc(-c3ccc4sc5ccccc5c4c3)cc(-c3cccc4c3sc3ccccc34)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.49
PIM1 P11309 2/20 0.39
PIM2 Q9P1W9 2/20 0.39
PIM3 Q86V86 2/20 0.39
LIMK1 P53667 2/20 0.38
PRSS12 P56730 1/20 0.38
PRKDC P78527 4/20 0.36
PARP14 Q460N5 1/20 0.36
PDK2 Q15119 1/20 0.35
GPR3 P46089 1/20 0.34
MAP4K4 O95819 1/20 0.33
PTGIR P43119 1/20 0.32
TNKS O95271 1/20 0.32
PIK3CD O00329 1/20 0.32
BRD4 O60885 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21693067 0.94 ALOX5 (0.55) ALOX5PIM1PIM2PIM3LIMK1
SCHEMBL21692375 0.93 ALOX5 (0.47) ALOX5PIM1PIM2PIM3LIMK1
SCHEMBL21693126 0.93 ALOX5 (0.49) ALOX5PIM1PIM2PIM3LIMK1
SCHEMBL21691710 0.93 ALOX5 (0.49) ALOX5PIM1PIM2PIM3LIMK1
SCHEMBL21692581 0.92 ALOX5 (0.46) ALOX5PIM1PIM2PIM3PRKDC
SCHEMBL21692574 0.92 ALOX5 (0.46) ALOX5PIM1PIM2PIM3PRKDC
SCHEMBL21691687 0.92 ALOX5 (0.48) ALOX5PRKDCPARP14PDK2MAP4K4
SCHEMBL21691682 0.90 ALOX5 (0.44) ALOX5PIM1PIM2PIM3LIMK1
SCHEMBL21692576 0.90 ALOX5 (0.44) ALOX5PIM1PIM2PIM3PRSS12
SCHEMBL16016629 0.89 ALOX5 (0.55) ALOX5LIMK1PRSS12PRKDCPARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885PIM1 3916/4885PIM2 4029/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885PIM1 3916/4885PIM2 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.